KOA Biotech is thrilled to announce a successful funding round of 2,000,000 dollars, marking a significant milestone in our mission to revolutionize the fish farming industry. Our innovative digital, autonomous, and onsite testing technology is designed to dramatically reduce fish mortality and cut operational costs by up to 50%. With over 50% of today’s fish consumption coming from aquaculture, our pioneering technology offers a much-needed alternative to the traditional method of sending water samples to remote laboratories—a process that can take anywhere from 5 to 10 days to deliver results. By enabling continuous monitoring of harmful bacteria in real-time, our onsite testing kits provide early warning alerts, allowing fish farm operators to swiftly address potential threats before they escalate into costly and life-threatening infections.
Rooted in groundbreaking research and innovation, KOA Biotech is a proud spinoff from the University of Pompeu Fabra, established by a group of dedicated PhDs in Biology. Our passion for sustainable food production is underscored by our commitment to not only enhancing fish health and farm economics but also reducing environmental impacts on a global scale. To date, we have two live tests running with customers who are already seeing substantial benefits, and we have secured eight additional Letters of Intent from prospective clients ready to go live in the next three months.
This new infusion of capital will propel our growth as we scale operations, refine our technology, and expand our market reach. We are excited to work with our investors, partners, and the broader community to drive sustainable innovation in fish farming, ultimately taking care of humanity and the planet. Join us on this exciting journey as we pave the way for a healthier, more sustainable future in aquaculture.
